E IR T Y vylife® Boussignac 1 device, 3 ventilation modes

advertisement
R
S
e
ion
t
a
il
t
en
R
I
P
V
Non
In
va
si
v
E
A
RY
O
T
vylife® Boussignac
1 device,
3 ventilation modes
vylife® Boussignac
vylife® Boussignac, 1 device, 3 ventilation modes
APNEA mode
NIV-2P mode
Return to spontaneous ventilation
following cardiac arrest
Non Invasive Ventilation with 2 levels of pressure
Mechanical ventilation
APNEA Mode
Transport of intubated patient
cmH2O
12
11
Interest of mechanical ventilation:
• Pressure control
• Physiological mechanical ventilation: in open system, lung elastance and compliance regulates the speed
and volume of gas
Insp.
Respiratory cycle in NIV-2P
IPAP
10
15
9
12
10
8
5
6
4
3
7
5
6
Exp.
5
EPAP
1
2
0
Temps
4
CPAP mode
3
Continuous Positive Airway Pressure (one pressure level)
1
0
-1
cmH2O
12
11
10
9
8
7
6
5
4
3
2
1
Spontaneous 0
ventilation
EPAP: Expiratory Positive Airway Pressure
Inspiratory trigger
3 IS (Inspiratory Support) = IPAP-EPAP
4 Slope: speed from expiratory pressure to inspiratory
pressure
5 IPAP: Inspiratory Positive Airway Pressure
6 Expiratory trigger
1
2
DELTA P
The Work Of Breathing (WOB)
is the expenditure of energy required to
inspire air in the lungs.
WOB
CPAP
7.5 cmH2O
Exp.
Insp.
2
Exp.
Insp.
Time
IPAP : Inspiratory Positive Airway Pressure
EPAP : Expiratory Positive Airway Pressure
Delta P
DELTA P
0
1
2
3
4
5
6
7
9
8
10
11
12
Atmospheric
pressure
is the difference between inspiratory
pressure and expiratory pressure.
COPD (Chronic Obstructive Pulmonary Disease) and Pneumopathy with hypoxemia
Time
Alveolar recruitment
Improvement of ventilation /
perfusion ratio
APE (Acute Pulmonary Edema)
COPD,
Pneumopathy
with hypoxemia
Alveolar recruitment
Pulmonary
volume
Improvment of ventilation /
perfusion ratio
Decrease the WOB
APE
Hypoxemia
Hemodynamic
Hypercapnia
PEP
(Positive
Expiratory Pressure)
Decrease the WOB
Increase of tidal volume
Decrease the WOB
NIV-2P
mode
IS
(Inspiratory Support)
CPAP
mode
Decrease
of venous return
Decrease
of left ventricular afterload
Proven interest of CPAP:
Proven interest of NIV-2P (5,6):
• Increased gazometric and ventilator parameters
• Decreased morbidity and mortality
• Decreased length of stay
• Reduced risk of reintubation
• Proven efficiency in the management of acute pulmonary edema (1,2)
• Avoids the need for tracheal intubation (3)
• Cost/benefit ratio shows a positive result in favour of CPAP in pre-hospital medical care (4)
2
3
vylife® Boussignac
vylife® Boussignac: all the advantages of Boussignac
CPAP + a trigger
1
Effective
CPAP mode (7,8)
• Flow rate of gas available for inspiration is 280 to 320 l/min
• The difference between inspiratory pressure and expiratory pressure (Delta P) is only
1.5 +/- 0.2 cmH2O (9)
• Regulation of inspired FiO2
3
Easy to use
• vylife® Boussignac starts with the chosen mode of ventilation and pressures
• Adjustable pressure with buttons “+” and “-”
• Inspiratory Support (IS)=IPAP-EPAP
• Portable
• Capnograph connection via interface or manometer port
Mode VNI-2P (10, 11)
• Pressurisation quality
• Accurate trigger
Easy to use:
+ increases pressure
- decreases pressure
2 Safe
vylife® Boussignac is an open system, if necessary the patient can breathe atmospheric air
and thus constantly breathe the required volume of gas.
The pressure in the lungs cannot be superior to the virtual valve (A):
Oxygen supply
Oxygen acceleration
Oxygen molecules arrive
in the chamber
Large screen:
Easy to read (ventilation mode,
pressures, battery, respiratory frequency)
Open system:
no risk of asphyxia
The oxygen molecules are accelerated
at the speed of sound when they pass trough
four micro-channels
Open to
atmosphere
Pressure (A)
Flow rate of gas available
280 – 320 L/min
Disposable kit:
ready to use
Creation of a virtual valve
The oxygen molecules collide with each other,
generating turbulence which transforms the speed
into pressure
Oxygen breaking
The oxygen molecules strike a deflector
which sends them back to the central zone
(mixing zone)
Pressure directly
depends on
flow rate of gas
Pressure monitoring
or administration of additional oxygen
or EtCO2 monitoring
When you increase the flow rate,
you increase the pressure
When you decrease the flow rate,
you decrease the pressure
No risk of barotrauma / volotrauma
No risk of hypoventilation
4
One click connection:
no risk of misconnection
Special “star”
shaped O2 tube:
Thanks to this design, the
patient will always get O2 even
if the tube is kinked
5
Complete range
Single use kit
vylife® kit without harness
vylife® kit with harness
Codes 5567.303 / 403 / 503 / 603
Codes 5568.303 / 403 / 503 / 603
Oxygen extension tube
Ringed tube
CPAP Boussignac
FiO2 ring
Trigger
Facial mask
Oxygen extension tube
Ringed tube
CPAP Boussignac
FiO2 ring
Trigger
Facial mask
O2 vylife® kit
Codes 5582.802 (AFNOR)
2 vylife® kits
1 vylife® charger
1 vylife®device
1 Rapid instructions for use
1 Oxygen stopcock
Codes 5582.700 (without Oxygen stopcock)
5568.303 / 403 / 503 / 603
2 vylife® kits
1 vylife® charger
1 vylife®device
1 Rapid instructions for use
5568.303 / 403 / 503 / 603
References
Hubble Mw, and al. Effectiveness of continuous positive airway pressure in the management of acute pulmonary edema. Prehosp Emerg
Care. 2006;10:430-439
(2)
Gray A et al. Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med. 2008;359:142-151
(3)
Wang He, and al. Medical conditions associated with out-of-hospital intubation. Prehosp Emerg Care. 2011;15:338-346
(4)
Hubble MW, and al. Estimates of cost-effectiveness of prehospital continuous positive airway pressure in the management of acute
pulmonary edema. Prehosp Emerg Care. 2008;12:277-285
(5)
Meduri Gu and al. Noninvasive positive pressure ventilation via face mask. First-line intervention in patients with acute hypercapnic and
hypoxemic respiratory failure. Chest 1996 Jan;109(1):179-93
(6)
Ram FS and al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive
pulmonary disease. Cochrane DatabaseSyst Rev. 2004;(3):CD004101
(7)
Templier F and al. Ann Fr Anest Reanim 2003 ;22 :103-7
(8)
Lyazidi A and al. Evaluation des systèmes à Pression Positive Continue (CPAP) sur banc d’essai. Hôpitaux Universitaires de Genève
(9)
P.Valero MD, A. Khoury MD, G. Capellier MD, Phd, D. Robert MD, Phd. Comparison between 3 devices delivering Continuous Positive
Airway Pressure (CPAP). Poster
(10)
Brochard L. et al. Evaluation d’un nouvel appareil de ventilation assistée portable : la Vylife Boussignac. Poster SRLF 2009
(11)
Jaber S. et al. Un nouveau ventilateur «léger», la Vylife - BiPAP Boussignac : évaluation sur banc test. Poster SFAR 2012
(1)
AUGUST 2013 / DB CPAP 13 207 E
For further information, please contact: questions@vygon.com
The specifications shown in this leaflet are for information only
and are not, under any circumstances, of a contractual nature.
Vygon – 5, rue Adeline • 95440 ECOUEN • FRANCE
Reception: +33 (0)1.39.92.63.63 – Service clients France: +33 (0)1.39.92.63.81
Export customer service: +33 (0)1.39.92.64.15
Fax: +33 (0)1.39.92.64.44 • www.vygon.com
www.vygon.com
Download